Cargando…

Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study

Detalles Bibliográficos
Autor principal: Longevity, Oxidative Medicine and Cellular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412365/
https://www.ncbi.nlm.nih.gov/pubmed/37565167
http://dx.doi.org/10.1155/2023/9828565
_version_ 1785086887146291200
author Longevity, Oxidative Medicine and Cellular
author_facet Longevity, Oxidative Medicine and Cellular
author_sort Longevity, Oxidative Medicine and Cellular
collection PubMed
description
format Online
Article
Text
id pubmed-10412365
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104123652023-08-10 Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study Longevity, Oxidative Medicine and Cellular Oxid Med Cell Longev Retraction Hindawi 2023-08-02 /pmc/articles/PMC10412365/ /pubmed/37565167 http://dx.doi.org/10.1155/2023/9828565 Text en Copyright © 2023 Oxidative Medicine and Cellular Longevity. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Longevity, Oxidative Medicine and Cellular
Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title_full Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title_fullStr Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title_full_unstemmed Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title_short Retracted: Clinical Efficacy of PEG-IFNα-2a and PEG-IFNα-2b in the Treatment of Hepatitis B e Antigen-Positive Hepatitis B and Their Value in Improving Inflammatory Factors and Hemodynamics in Patients: A Comparative Study
title_sort retracted: clinical efficacy of peg-ifnα-2a and peg-ifnα-2b in the treatment of hepatitis b e antigen-positive hepatitis b and their value in improving inflammatory factors and hemodynamics in patients: a comparative study
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412365/
https://www.ncbi.nlm.nih.gov/pubmed/37565167
http://dx.doi.org/10.1155/2023/9828565
work_keys_str_mv AT longevityoxidativemedicineandcellular retractedclinicalefficacyofpegifna2aandpegifna2binthetreatmentofhepatitisbeantigenpositivehepatitisbandtheirvalueinimprovinginflammatoryfactorsandhemodynamicsinpatientsacomparativestudy